Pharmaceutical Accountability Foundation

Pharmaceutical Accountability Foundation

Striving for equal access to medicines and medical technologies

Access to medicines is a human right

At Pharmaceutical Accountability Foundation, we believe the pharmaceutical industry has to be held accountable when they limit needed access by raising prices to unsustainable levels in pursuit of unfair profits. We therefore investigate cases of pharmaceutical company abuse of market exclusivity rights to keep prices high at the expense of public health. We then work to inform the public, or take legal action if necessary.

Issues

Why is medical technology so very expensive? There are many issues in the way we currently incentivise innovation.

Solutions

There are several legal and policy solutions to stop misconduct, high prices, and limited access to medicines.

Cases

Examples of excessive pricing we have marked for investigation, or find illustrative of systemic challenges.

Recent News

EVENT: Discussing pharmaceutical human rights accountability during Covid-19

The Pharmaceutical Accountability Foundation is organising an event on its Good Covid-19 Company Practices (GCCP) project on september 30th 2021, 15:00-16:30 CET. The event will be...

EVENT: Discussing pharmaceutical human rights accountability during Covid-19

An Expert Panel Discussion on Good Covid-19 Company Practices (GCCP) The Pharmaceutical Accountability Foundation is organising an event on its Good Covid-19 Company Practices (GCCP) project...

Dutch Competition Authority ACM honors PAFs enforcement request and fines pharmaceutical company Leadiant with €19.5 million

Bergeijk, July 19, 2021 On September 7, 2018, the Pharmaceutical Accountability Foundation (PAF) submitted an enforcement request  for abuse of a dominant market position by the...

Moderna funnels billions and patents to tax havens

Research by SOMO and Wemos has shown that the EU has transferred an amount of more than 10 billion dollars to the Swiss bank account...

Recent Tweets

⁦WHO’s ⁦@DrTedros⁩ “appalled” at comments by a leading association of pharma manufacturers (I guess ⁦@IFPMA⁩ ) who said vaccine supplies are high enough to allow for both booster shots and vaccinations in countries in dire need of jabs. https://www.pbs.org/newshour/world/who-chief-urges-halt-to-booster-shots-for-rest-of-the-year

Load More...